CMC – Page 23 – Pharma.Tips

R&D Scale-Up Failures? Development-to-Manufacturing Solutions

Managing R&D Scale-Up Challenges: Solutions for Smooth Development to Manufacturing Transition The transition from research and development (R&D) to manufacturing can often encounter significant obstacles that impede the scale-up process.…

Submission Delays and Deficiencies? Regulatory Affairs Solutions

Addressing Regulatory Submission Delays and Deficiencies in Pharma Operations Delays in regulatory submissions and deficiencies identified by health authorities can have far-reaching consequences for pharmaceutical companies, impacting timelines, budgets, and…

Orphan Drug Development Bottlenecks? Smarter CMC and Regulatory Solutions

Overcoming Development Hurdles in Orphan Drug Manufacturing and Regulatory Affairs The pathway to developing orphan drugs presents unique challenges that can hinder progress and increase costs. As pharmaceutical professionals in…

Biosimilar Comparability Gaps? Analytical and Regulatory Pathway Solutions

Addressing Comparability Gaps in Biosimilars: Analytical and Regulatory Pathway Solutions Biosimilars offer promising opportunities in therapeutic efficacy while being cost-effective alternatives to original biologics. However, concerns about comparability can arise…

Tech Transfer Delays and Scale-Up Failures? Practical Solutions From Lab to Commercial

Overcoming Delays in Tech Transfer and Scale-Up in Pharmaceutical Manufacturing In the highly regulated environment of pharmaceutical manufacturing, tech transfer delays and scale-up failures can lead to significant losses, both…

Product-Type Compliance Gaps? How to Manage Quality Risks Across Therapeutic Categories

Addressing Compliance Gaps in Product Types Across Therapeutic Categories Compliance with product quality standards across therapeutic categories remains a significant challenge in pharmaceutical manufacturing. Organizations face various quality risks that…